{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:59:12Z","timestamp":1784807952899,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ymgme.2020.10.013","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T23:00:26Z","timestamp":1604703626000},"page":"390-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders"],"prefix":"10.1016","volume":"131","author":[{"given":"Roland","family":"Posset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Gleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen G.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Gropman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh C.S.","family":"Nagamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Scharre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg F.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven F.","family":"Garbade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Zielonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.10.013_bb0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"Members of the urea cycle disorders C. a longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2020.10.013_bb0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-017-0661-x","article-title":"Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland","volume":"12","author":"Nettesheim","year":"2017","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.10.013_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jimd.12031","article-title":"Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-a successful strategy for clinical research of rare diseases","volume":"42","author":"Posset","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.10.013_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2020.10.013_bb0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jimd.12047","article-title":"Argininosuccinic aciduria: recent pathophysiological insights and therapeutic prospects","volume":"42","author":"Baruteau","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2020.10.013_bb0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation","volume":"38","author":"Kolker","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2020.10.013_bb0035","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"Haberle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.10.013_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1172-6-44","article-title":"Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from south-West Germany","volume":"6","author":"Lindner","year":"2011","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.10.013_bb0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ymgme.2010.01.013","article-title":"Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria","volume":"100","author":"Mercimek-Mahmutoglu","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2020.10.013_bb0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10545-016-9938-9","article-title":"Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders","volume":"39","author":"Posset","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.10.013_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.25492","article-title":"Impact of diagnosis and therapy on cognitive function in urea cycle disorders","volume":"86","author":"Posset","year":"2019","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2020.10.013_bb0060","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/humu.23983","article-title":"From genotype to phenotype: early prediction of disease severity in argininosuccinic aciduria","volume":"41","author":"Zielonka","year":"2020","journal-title":"Hum. Mutat."},{"issue":"9","key":"10.1016\/j.ymgme.2020.10.013_bb0065","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/acn3.50886","article-title":"Early prediction of phenotypic severity in Citrullinemia type 1","volume":"6","author":"Zielonka","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.10.013_bb0070","doi-asserted-by":"crossref","first-page":"11948","DOI":"10.1038\/s41598-020-67496-3","article-title":"Long-term effects of medical management on growth and weight in individuals with urea cycle disorders","volume":"10","author":"Posset","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2020.10.013_bb0075","first-page":"1","article-title":"The strucplot framework: visualizing multi-way contigency tables with vcd","volume":"17","author":"Hornik","year":"2006","journal-title":"J. Stat. Softw."},{"issue":"6","key":"10.1016\/j.ymgme.2020.10.013_bb0080","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1086\/426318","article-title":"A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening","volume":"75","author":"Ensenauer","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2020.10.013_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10545-011-9419-0","article-title":"Propionic acidemia: neonatal versus selective metabolic screening","volume":"35","author":"Grunert","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.10.013_bb0090","first-page":"5","article-title":"Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: selective screening vs. expanded newborn screening","volume":"16","author":"Shibata","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2020.10.013_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0168-8278(99)80361-4","article-title":"Pathophysiology of cerebral edema in fulminant hepatic failure","volume":"31","author":"Blei","year":"1999","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.ymgme.2020.10.013_bb0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron."},{"issue":"3903","key":"10.1016\/j.ymgme.2020.10.013_bb0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.166.3903.386","article-title":"Brain lesions in an infant rhesus monkey treated with monsodium glutamate","volume":"166","author":"Olney","year":"1969","journal-title":"Science."},{"issue":"9","key":"10.1016\/j.ymgme.2020.10.013_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203707","article-title":"Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase","volume":"13","author":"Zielonka","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2020.10.013_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.expneurol.2019.01.008","article-title":"Bioenergetic dysfunction in a zebrafish model of acute hyperammonemic decompensation","volume":"314","author":"Zielonka","year":"2019","journal-title":"Exp. Neurol."},{"issue":"22","key":"10.1016\/j.ymgme.2020.10.013_bb0120","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa066596","article-title":"Survival after treatment with phenylacetate and benzoate for urea-cycle disorders","volume":"356","author":"Enns","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2020.10.013_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10545-011-9427-0","article-title":"Long-term outcome and intervention of urea cycle disorders in Japan","volume":"35","author":"Kido","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2020.10.013_bb0130","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/ped.12439","article-title":"Diagnosis and treatment of urea cycle disorder in Japan","volume":"56","author":"Nakamura","year":"2014","journal-title":"Pediatr. Int."},{"issue":"6","key":"10.1016\/j.ymgme.2020.10.013_bb0135","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00431-003-1188-9","article-title":"Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur. J. Pediatr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2020.10.013_bb0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005374027693","article-title":"Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan","volume":"21","author":"Uchino","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2020.10.013_bb0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10545-017-0022-x","article-title":"Expanding the phenotype in argininosuccinic aciduria: need for new therapies","volume":"40","author":"Baruteau","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.10.013_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.c.30289","article-title":"Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond","volume":"157C","author":"Erez","year":"2011","journal-title":"Am. J. Med. Genet. C Semin Med. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2020.10.013_bb0155","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.cell.2012.04.031","article-title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins","volume":"149","author":"Castello","year":"2012","journal-title":"Cell."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220302134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220302134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:26:20Z","timestamp":1761089180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220302134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1096719220302134"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.10.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}